Skip to content

Study · Other design · 1988

4 results

Oxytocin increases arginine-induced A and B cell secretion in normal man and in diabetic subjects.

Paolisso G, Sgambato S, Passariello N, Giugliano D, Torella R, Memoli P, Varricchio M, D'Onofrio F

Diabete & metabolisme1 Mar 1988Cited by 3 (Europe PMC)

PMID3042483 (opens in a new tab)PepBankPUB-03042483
Publisher pageAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. 4 results from people.

  1. 01HumanOther designEfficacy outcome

    In healthy people, oxytocin increased arginine-induced glucagon secretion.

    In plain wordsIn healthy people, oxytocin raised the glucagon response to arginine.

    Peptide
    Oxytocin
    Outcome
    IncreaseArginine-induced glucagon secretion in healthy people
    Study

    n: not reported in source

    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In the present study we show that oxytocin is also able to increase arginine-induced glucagon and insulin secretion in healthy human beings.
  2. 02HumanOther designEfficacy outcome

    In healthy people, oxytocin increased arginine-induced insulin secretion.

    In plain wordsIn healthy people, oxytocin raised the insulin response to arginine.

    Peptide
    Oxytocin
    Outcome
    IncreaseArginine-induced insulin secretion in healthy people
    Study

    n: not reported in source

    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In the present study we show that oxytocin is also able to increase arginine-induced glucagon and insulin secretion in healthy human beings.
  3. 03HumanOther designEfficacy outcome

    In people with insulin-dependent (type 1) diabetes, oxytocin increased arginine-induced glucagon and insulin secretion, similar to healthy people.

    In plain wordsIn people with type 1 diabetes, oxytocin raised the glucagon and insulin response to arginine, as in healthy people.

    Peptide
    Oxytocin
    Outcome
    IncreaseArginine-induced A and B cell secretion in type 1 diabetes
    Study

    n: not reported in source

    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Similar results were obtained in both insulin-dependent (type-1) and non-insulin dependent (type-2) diabetic subjects.
  4. 04HumanOther designEfficacy outcome

    In people with non-insulin dependent (type 2) diabetes, oxytocin increased arginine-induced glucagon and insulin secretion, similar to healthy people.

    In plain wordsIn people with type 2 diabetes, oxytocin raised the glucagon and insulin response to arginine, as in healthy people.

    Peptide
    Oxytocin
    Outcome
    IncreaseArginine-induced A and B cell secretion in type 2 diabetes
    Study

    n: not reported in source

    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Similar results were obtained in both insulin-dependent (type-1) and non-insulin dependent (type-2) diabetic subjects.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.